Q4 2023 update: M&A activity in pharmaceutical in North America
In value terms, M&A activity in North America increased by 260% in Q4 2023 compared with the previous quarter’s total of $18bn and rose by 287% as compared to Q4 2022. Related deal volume increased by 9% in Q4 2023 versus the previous quarter and was …